BB
The startup develops immunomodulatory proteins that enhance the anti-tumor immune response for cancer treatment. By utilizing a novel technology to generate a series of these proteins, the company aims to improve patient outcomes in oncology.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops immunomodulatory proteins that enhance the anti-tumor immune response for cancer treatment. By utilizing a novel technology to generate a series of these proteins, the company aims to improve patient outcomes in oncology.